Healthcare
Duo Oncology – SUCCESS PAGE – Recorded December 04, 2025
Duo Oncology is a next-generation biotech company creating a nanomedicine platform that replaces chemotherapy for hard-to-treat cancers
Duo Oncology is a next-generation biotech company creating a nanomedicine platform that replaces chemotherapy for hard-to-treat cancers
Duo Oncology is a next-generation biotech company creating a nanomedicine platform that replaces chemotherapy for hard-to-treat cancers
Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain
Xgene is using its proprietary conjugate platform technology to provide highly effective non-opioid relief for acute and chronic pain
Boost Fertility has developed a medical device that makes Clinical-grade fertility treatment that everyone can afford
Hummingbird Tube System enables ear tube placement for children at a doctor’s office in just minutes, dramatically reducing healthcare costs
Breakthru Medicine is developing precision cancer therapies targeting an $18B+ solid cancer market with massive unmet need
Auctus Vertical Body Tethering has received a Breakthrough Device Designation and Humanitarian Device Exemption Pathway from the FDA
BrainScope has a pipeline that spans stroke, Alzheimer’s, concussion, and beyond, and is uniquely positioned in a $21B+ global market
Breakthru Medicine is developing precision cancer therapies targeting an $18B+ solid cancer market with massive unmet need
AvenCell Therapeutics is pioneering the next generation of cancer treatment with powerful, persistent, and switchable allogeneic CAR-T therapies
Vantis Vascular is developing breakthrough tools to deliver game-changing outcomes in advanced vascular intervention